Home / Market News / $OPGX

$OPGX news and market catalysts

The 1 most recent market catalysts affecting $OPGX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

1 catalysts 1 high impact 1 bullish 0 bearish Biotechnology

Sep 2, 2026 Corporate Catalyst Bullish Impact 85

Opus Genetics shares are trading higher after the company announced plans to present topline clinical data from Cohort 1 of its Phase 1/2 study of OPGx-BEST1 in investor webcast and upcoming Ophthalmology conferences.

The announcement of presenting topline clinical data from a Phase 1/2 study is a major positive catalyst for Opus Genetics. Positive results from early-stage clinical trials signif…

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.